The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.
about
Advances in mass spectrometry-based cancer research and analysis: from cancer proteomics to clinical diagnostics.Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsDetection and localization of surgically resectable cancers with a multi-analyte blood test.Proteomics for early detection of colorectal cancer: recent updates.Utilizing Ion Mobility to Identify Isobaric Post-Translational Modifications: Resolving Acrolein and Propionyl Lysine Adducts by TIMS Mass Spectrometry
P2860
The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The clinical impact of recent ...... er discovery and verification.
@ast
The clinical impact of recent ...... er discovery and verification.
@en
type
label
The clinical impact of recent ...... er discovery and verification.
@ast
The clinical impact of recent ...... er discovery and verification.
@en
prefLabel
The clinical impact of recent ...... er discovery and verification.
@ast
The clinical impact of recent ...... er discovery and verification.
@en
P2093
P2860
P1476
The clinical impact of recent ...... er discovery and verification.
@en
P2093
David G Camp
Jacob Kagan
Karin D Rodland
Richard D Smith
Sudhir Srivastava
P2860
P304
P356
10.1586/14789450.2016.1122529
P50
P577
2015-11-18T00:00:00Z